HOME > OUR BUSINESS > API

MANUFACTURING SITES

Manufacturing is at the heart of Lupin’s Philosophy of Execution Excellence.

Lupin has currently 5 operational manufacturing sites dedicated to API production.

In addition we have recently undertaken building of a new Greenfield API site at Pharma City in Vizag, for both Non-Oncology and Oncology APIs to augment manufacturing capacity.

ANKLESHWAR
  • Regulatory Approvals: WHO, UK MHRA, ANVISA Brazil, Korean FDA, CDSCO India, FDA, CCA, WHO GMP, EDQM, ISO – 14001, OSHAS - 18001
  • Product manufactured: Intermediates and API
  • Number of Plants : 9
  • Key markets served: Italy, China, Canada, India
TARAPUR
  • Regulatory Approvals: USFDA, UK MHRA, WHO
  • Product manufactured: API (Fermentation based and synthetic)
  • Number of Plants : 14 Manufacturing Plant and 5 Solvent Recovery blocks
  • Key markets served: US,EU, India, WHO Supplies, Japan
VADODARA (DABHASA)
MANDIDEEP
INDORE (PITHAMPUR)
VISHAKAPATNAM
  • New Facility
  • Dedicated Oncology Block with expandable area
  • Separate non –oncology Block with expandable area
  • Plant expected to be operational by Early FY’17